{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T18:53:05Z","timestamp":1767207185600,"version":"build-2238731810"},"reference-count":17,"publisher":"Jaypee Brothers Medical Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7,1]]},"DOI":"10.5005\/jp-journals-10018-1102","type":"journal-article","created":{"date-parts":[[2014,9,22]],"date-time":"2014-09-22T03:33:19Z","timestamp":1411356799000},"page":"59-62","source":"Crossref","is-referenced-by-count":4,"title":["Serum Resistin Level and Its Receptor Gene Expression in\nLiver Biopsy as Predictors for the Severity of\nNonalcoholic Fatty Liver Disease"],"prefix":"10.5005","volume":"4","author":[{"given":"Mona","family":"Hegazy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soheir","family":"Abo-Elfadl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeer","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdy","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Salman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","published-online":{"date-parts":[[2013,7,1]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"1. Desai P, Tamarapu Parthasarathy P, Galam L, Lockey R,\nKolliputi N. A new role for inflammasomes: sensing the\ndisturbances in non-alcoholic fatty liver disease. Front\nPhysiol 2013 Jul 1;4:156","DOI":"10.3389\/fphys.2013.00156"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Baranova A, Tran TP, Afendy A, Wang L, Shamsaddini A,\nMehta R, Chandhoke V, Birerdinc A, Younossi ZM. Molecular\nsignature of adipose tissue in patients with both non-alcoholic\nfatty liver disease (NAFLD) and polycystic ovarian syndrome\n(PCOS). J Transl Med 2013 May 31;11:133","DOI":"10.1186\/1479-5876-11-133"},{"key":"ref=3","unstructured":"Parkash O, Hamid S. Are we ready for a new epidemic of\nunder recognized liver disease in South Asia especially in\nPakistan? Non-alcoholic fatty liver disease. J Pak Med Assoc\n2013 Jan;63(1):95-99"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Fierbinteanu-Braticevici C, Dina I, Petrisor A, Tribus L,\nNegreanu L, Carstoiu C. Noninvasive investigations for\nnon-alcoholic fatty liver disease and liver fibrosis. World J\nGastroenterol 2010 Oct 14;16(38):4784-4791","DOI":"10.3748\/wjg.v16.i38.4784"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Ye H, Zhang HJ, Xu A, Hoo RL. Resistin production from\nadipose tissue is decreased in db\/db obese mice, and is\nreversed by rosiglitazone. PLoS One 2013 Jun 12;8(6):e65543","DOI":"10.1371\/journal.pone.0065543"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Gupta V, Singh AK, Gupta V, Kumar S, Srivastava N, Jafar T,\nPant AB. Association of circulating resistin with metabolic\nrisk factors in Indian females having metabolic syndrome.\nToxicol Int 2011 Jul;18(2):168-172","DOI":"10.4103\/0971-6580.84272"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Gandhi H, Upaganlawar A, Balaraman R. Adipocytokines: The\npied pipers. J Pharmacol Pharmacother 2010 Jan;1(1):9-17","DOI":"10.4103\/0976-500X.64530"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W,\nKerr K, Jones R, Zhu Q, Considine RV. Serum resistin (FIZZ3)\nprotein is increased in obese humans. J Clin Endocrinol\nMetab 2003 Nov;88(11):5452-5455","DOI":"10.1210\/jc.2002-021808"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behlling C, Contos MJ,\nCummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-\nArida A, et al. Design and validation of a histologic scoring\nsystem for nonalcoholic fatty liver disease. Hepatology 2005\nJun;41(6):1313-1321","DOI":"10.1002\/hep.20701"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Brunt EM, Kleiner DE, Wilson LA, Unalp A, Behling CE,\nLavine JE, Neuschwander-Tetri BA. NASH clinical research\nnetwork a list of members of the nonalcoholic steatohepatitis\nclinical research network can be found in the appendix. Portal\nchronic inflammation in nonalcoholic fatty liver disease\n(NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic\ncorrelations from the nonalcoholic steatohepatitis\nclinical research network. Hepatology 2009 Mar;49(3):809-820","DOI":"10.1002\/hep.22724"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"VanGuilder HD, Vrana KE, Freeman WM. Twenty-five years\nof quantitative PCR for gene expression analysis. Biotechniques\n2008 Apr;44(5):619-626","DOI":"10.2144\/000112776"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression\ndata using real-time quantitative PCR and the 2 [(-delta-delta\nC (T)] method. Methods 2001 Dec;25(4):402-408","DOI":"10.1006\/meth.2001.1262"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Marchesini G, Moscatiello S, Agostini F, Villanova N, Festi\nD. Treatment of non-alcoholic fatty liver disease with focus\non emerging drugs. Expert Opin Emerg Drugs 2011 Mar;\n16(1):121-36","DOI":"10.1517\/14728214.2011.531700"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Jiang LL, Li L, Hong XF, Li YM, Zhang BL. Patients with nonalcoholic\nfatty liver disease display increased serum resist in\nlevels and decreased adiponectin levels. Eur J Gastroenterol\nHepatol 2009 Jun;21(6):662-666","DOI":"10.1097\/MEG.0b013e328317f4b5"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Pagano C, Soardo G, Pilon C, Milocco C, Basan L, Milan G,\nDonnini D, Faggian D, Mussap M, Plebani M, et al.\nIncreased serum resistin in nonalcoholic fatty liver disease\nis related to liver disease severity and not to insulin resistance.\nJ Clin Endocrinol Metab 2006 Mar;91(3):1081-1086","DOI":"10.1210\/jc.2005-1056"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy\nM, Stepanova M, Rafig N, Goodman Z, Chandhoke V,\net al. A novel diagnostic biomarker panel for obesity-related\nnonalcoholic steatohepatitis (NASH). Obes Surg 2008 Nov;\n18(11):1430-1437","DOI":"10.1007\/s11695-008-9506-y"},{"key":"ref=17","unstructured":"Zhao CY, Yan L, Wang YD, Wang W, Zhou JY, Zhen Z. Role\nof resistin in inflammation of hepatocytes in non-alcoholic\nsteatohepatitis. Zhonghua Gan Zang Bing Za Zhi 2009 Sep;\n17(9):683-687."}],"container-title":["Euroasian Journal of Hepato-Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ejohg.com\/doi\/pdf\/10.5005\/jp-journals-10018-1102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T12:11:45Z","timestamp":1653999105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ejohg.com\/doi\/10.5005\/jp-journals-10018-1102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,1]]},"references-count":17,"aliases":["10.5005\/jp-journals-10018-1102i"],"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014]]}},"alternative-id":["10.5005\/jp-journals-10018-1102"],"URL":"https:\/\/doi.org\/10.5005\/jp-journals-10018-1102","relation":{},"ISSN":["2231-5047","2231-5128"],"issn-type":[{"value":"2231-5047","type":"print"},{"value":"2231-5128","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,1]]}}}